MAPT and cancer: The FAM-LPM was developed using fifteen prognostic FAM-associated lncRNAs, namely, CYTOR, LINC00894,[60] LINC01126,[61] AGAP2-AS1,[62] MIAT,[63] MIRLET7BHG, SNHG4, AATBC, WT1-AS,[64] SNHG17, C3orf35, TCL6,[65] MAPT-AS1, LINC00271, and BDNF-AS, some of these lncRNAs were identified as immune-related by Pearson’s correlation test and are closely associated with cancer etiology and the prognosis of cancer patients.